As I reported in a previous article, the company’s CEO, David Dodd, wrote in May that the firm’s “vaccines have been validated and registered for [the] prevention of Monkeypox virus infection.” And, in the same post, Dodd specified that one of the company’s shots may stop humans from contracting monkeypox.
Elaborating in June, the CEO reported that: “We already have published in peer-reviewed journals that our MVA vaccines, in addition [to] protecting animal models against HIV and other infections, also prevents monkeypox,” He vowed that his company would “address the monkeypox virus.”
Market Data 
Markets 
AI
